- Compound Valsartan
- Class Angiotensin II receptor blockers
- Human Studies Yes
- FDA Approved Yes
Valsartan: an angiotensin-II antagonist that is being examined for prevention of acute respiratory distress syndrome (ARDS) in patients with COVID-19.
RELATED PROJECTS
